Evidence map›Paper›PMID 32070311›Full record

Observational studyBMC palliative care2020

Implementation of the milestones communication approach for patients with limited prognosis: evaluation of intervention fidelity.

Jasmin Bossert, Michel Wensing, Michael Thomas, Matthias Villalobos, Corinna Jung, Anja Siegle, Laura Hagelskamp, Nicole Deis, Jana Jünger, Katja Krug

Abstract readObservational Study
In one paragraph

Observational study in BMC palliative care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Illness trajectories of incurable solid cancers.BMJ (Clinical research ed.) · 2024
    Article
  5. Consideration of sense of coherence in a structured communication approach with stage IV lung cancer patients and their informal caregivers: a qualitative interview study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  6. Canadian oncology nursing journal = Revue canadienne de nursing oncologique · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jasmin BossertDepartment of General Practice and Health Service Research, University Hospital Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany. jasmin.bossert@med.uni-heidelberg.de.
Michel WensingDepartment of General Practice and Health Service Research, University Hospital Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.
Michael ThomasDepartment of Thoracic Oncology, Thoraxklinik Heidelberg, Heidelberg University Hospital, Röntgenstraße 1, D-69126, Heidelberg, Germany.
Matthias VillalobosDepartment of Thoracic Oncology, Thoraxklinik Heidelberg, Heidelberg University Hospital, Röntgenstraße 1, D-69126, Heidelberg, Germany.
Corinna JungDepartment of Thoracic Oncology, Thoraxklinik Heidelberg, Heidelberg University Hospital, Röntgenstraße 1, D-69126, Heidelberg, Germany.
Anja SiegleDepartment of Thoracic Oncology, Thoraxklinik Heidelberg, Heidelberg University Hospital, Röntgenstraße 1, D-69126, Heidelberg, Germany.
Laura HagelskampDepartment of Thoracic Oncology, Thoraxklinik Heidelberg, Heidelberg University Hospital, Röntgenstraße 1, D-69126, Heidelberg, Germany.
Nicole DeisInstitute of Medical and Pharmaceutical Proficiency Assessment, Malakoff Passage, Rheinstraße 4, D-55116, Mainz, Germany.
Jana JüngerInstitute of Medical and Pharmaceutical Proficiency Assessment, Malakoff Passage, Rheinstraße 4, D-55116, Mainz, Germany.
Katja KrugDepartment of General Practice and Health Service Research, University Hospital Heidelberg, Im Neuenheimer Feld 130.3, 69120, Heidelberg, Germany.

Funding

Bundesministerium für Gesundheit 1504-54401
6 · The paper itself

Abstract

backgroundDespite improvements in diagnostics and therapy, the majority of lung tumours are diagnosed at advanced stage IV with a poor prognosis. Due to the nature of an incurable disease, patients need to engage in shared decision making on advance care planning. To implement this in clinical practice, effective communication between patients, caregivers and healthcare professionals is essential. The Heidelberg Milestones Communication Approach (MCA) is delivered by a specifically trained interprofessional tandem and consists of four milestone conversations (MCs) at pivotal times in the disease trajectory. MC 1 (Diagnosis): i.e. prognosis; MC 2 (Stable disease): i.e. prognostic awareness; MC 3 (Progression): i.e. reassessment; MC 4 (Best supportive care): i.e. end of treatment. In between MCs, follow-up calls are carried out to sustain communication. This study aimed to assess to what extent the MCA was implemented as planned and consolidated in specialized oncology practice.

methodsA prospective observational process evaluation study was conducted, which focused on the implementation fidelity of the MCA. All MCs during two assessment periods were included. We analysed all written records of the conversations, which are part of the routine documentation during MCs and follow-up calls. Adherence to key aspects of the manual was documented on structured checklists at the beginning of the implementation of the MCA and after 6 months. The analysis was descriptive. Differences between the two assessment periods are analysed with chi-square tests.

resultsA total of 133 MCs and 54 follow-up-calls (t1) and of 172 MCs and 92 follow-up calls (t2) were analysed. MC 2 were the most frequently completed conversations (n = 51 and n = 47). Advance care planning was discussed in 26 and 13% of MC 2 in the respective assessment periods; in 31 and 47% of MC 2, prognostic awareness was recorded. The most frequently documented topic in the follow-up calls was the physical condition in patients (82 and 83%).

conclusionThe implementation of a trajectory-specific communication concept was largely successful. Additional studies are needed to understand how fidelity could be further improved.

trial registrationDRKS00013469 / Date of registration: 22.12.2017.

Indexed as

Professional-Patient RelationsPrognosisAdultFemaleFollow-Up StudiesGermanyHumansLung NeoplasmsMaleMiddle AgedProspective StudiesAdvances care planningCommunicationLung cancerPatient preferencesPrognostic awareness

Identifiers

PMID32070311
PMCPMC7029500

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.